HOME >> BIOLOGY >> NEWS
Delirium high in ICU patients, leads to death, morbidity

There are an estimated 6,000 intensive care units in the United States caring for approximately 55,000 patients daily. Between 60 percent to 80 percent of these patients develop a brain dysfunction known as delirium, which according to a group of physicians at Vanderbilt Medical Center is an independent predictor of mortality.

In the April 14 issue of "The Journal of the American Medical Association," E. Wesley Ely, M.D., associate professor of Medicine and Research, and his team provided the first documented study to include daily measurements of delirium in the Intensive Care Unit, pointing to longer hospital stays and a three-fold increase in death.

"The dilemma in critical care is that people often develop brain dysfunction or delirium in the ICU setting which is thought to be of no real importance to survival or long-term quality of life," Ely said. "Frankly, it's been overlooked by medical teams for years and is simply called 'ICU psychosis.'"

"Five years ago, we began studying delirium in the ICU at Vanderbilt, after realizing that older people are more frequently going to ICUs and the added risk of developing brain dysfunction was present."

The JAMA piece titled "Delirium as a Predictor of Mortality in Mechanically-Ventilated Patients in the Intensive Care Unit" is a culmination of the work to date, Ely said.

"We have found that using the most robust statistical methods available to adjust for the severity of illness, age, coma and drugs used for sedation, the development of delirium presents the patients with a 300 percent increased likelihood of dying by six months as compared to similar patients who didn't develop delirium," Ely said.

"All of this work is ultimately leading us down the path of delirium prevention and treatment," he said. "Right now there are no data from randomized trials proving the best treatment. Secondly, delirium is grossly under-recognized so even if we knew how to treat it, nurses and doctors
'"/>

Contact: Clinton Colmenares
clinton.colmenares@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
16-Apr-2004


Page: 1 2 3

Related biology news :

1. Hospitalization injuries prove costly to patients, health care system
2. For spinal cord injury patients, new insights for rehabilitation therapy
3. MIT sugars research affecting bypass patients, drug industry
4. Loss of the neuronal adhesion protein d-catenin leads to severe cognitive dysfunction
5. Cockroach-like robot leads new research effort
6. Washington University in St. Louis leads group studying aging process
7. Green tea research leads to gum and other products
8. Cancer drug resistance research leads to possible therapeutic target for Alzheimers disease
9. Research into cetacean reproduction leads to birth of killer whales by artificial insemination
10. UCSD finds genetic time bomb in heart that leads to heart failure in some patients
11. Meeting of the minds leads new era in fight against cancer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Delirium high ICU patients leads death morbidity

(Date:6/18/2013)... Scientists at the University of Calgary,s Faculty of Medicine ... the body from harmful bacteria. Platelets, a component of ... search for specific bacteria, and upon detection, seal it ... which were published in Nature Immunology this ... of immunity. , "The science community has known that ...
(Date:6/18/2013)... University, sophisticated computational models and advances in graphical ... interplay between genomic data, virus structure and the ... for replication. , "We hope that ... researchers alter virus assembly, leaving viruses unable to ... of the scientific paper describing the technique, published ...
(Date:6/18/2013)... National Institutes of Health has awarded $12.7 million ... selection of pharmaceutical industry compounds to explore new ... Alzheimer,s disease, Duchenne muscular dystrophy and schizophrenia. The ... for Existing Molecules, is led by the National ... by the NIH Common Fund. , The process ...
Breaking Biology News(10 mins):Immunity mechanism discovered 2Computer modeling technique goes viral at Brandeis 2NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4
(Date:6/19/2013)... , June 19, 2013 MO BIO ... and other challenging microbial nucleic acid purification, announces ... Kit, for extraction of pure protein from all ... coincides with the 20 th anniversary of ... capabilities. (Photo: http://photos.prnewswire.com/prnh/20130619/LA32633 ) ...
(Date:6/19/2013)... Bayer CropScience will honor Illinois beekeeper Steve ... Leadership Award. The award will be announced at Bayer’s ... D.C., an event where supporters of pollinator health celebrate ... , The Bayer Bee Care Community Leadership Award ... honey bee colony to benefit their community. Applicants are ...
(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ ... Bureau presents Innovative Drug Delivery ... Technology Licensing Opportunities for Generic ... There are more ... release drugs approved all over ...
(Date:6/19/2013)... 19, 2013 Applied Rigaku Technologies, Inc. ... details the measurement of sulfur in ultra-low sulfur diesel ... resolution benchtop EDXRF analyzer . The analysis detailed in ... ISO 13032. This International Standard specifies an energy ... of sulfur content in automotive gasoline. , Regulations around ...
Breaking Biology Technology:MO BIO Laboratories, Inc. launches the first kit for protein extraction from soil 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 3Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 4Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 2
Cached News: